Company intelligence / Profile preview

Shanghai Y&L

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shanghai YL Biotech is a China-based life science reagents company focused on immune detection and research-use biological products rather than therapeutic drug development. The company markets a broad catalog of ELISA kits, CLIA kits, antibodies, proteins, and related assay reagents, with public materials indicating more than 20,000 products. Its business appears centered on research, production, sales, and OEM supply for laboratory and diagnostics-related customers. Based on available sources, the company is an active private supplier of life science tools in Shanghai and does not appear to operate a clinical therapeutics pipeline.

Therapeutic areas: Other
Modalities: BiologicProteinAntibody
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Shanghai Y&L.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Y&L.

Explore the full profile